PRP Hair Loss Protocol: Draw, Spin, Depth, Schedule
PRP Hair Loss Protocol
Two clinics can both hand you a page that says "PRP for hair loss" and inject you with genuinely different products. What separates them isn't the name on the brochure, it's the written specification underneath it: how much blood comes out of your arm, how hard and how long it gets spun, how concentrated the platelets end up, and how deep the needle goes. The protocol is the product, and if nobody wrote it down, nobody can repeat it.
A PRP hair loss protocol fixes draw volume, anticoagulant, spin force and time, platelet multiple, leukocyte content, injection depth of 1.5 to 2.5 millimeters, and session interval, and changing any one of those variables changes what actually reaches the follicle.
What defines a standardized PRP protocol for hair loss and why does standardization matter?
Anything you leave unspecified doesn't disappear, it just becomes whoever happens to be running the centrifuge that day. That's the whole reason the published PRP literature reads like a shouting match: a single spin at 1,500 g for five minutes and a double spin at 3,000 g are two different treatments wearing the same three letters. Standardization is simply the decision to write every consequential variable down and then actually follow it.
- Report spin in g, not rpm: rotor radius differs, so the same rpm delivers different force.
- Run your kit as validated: a cleared kit ships with tested spin parameters and expected yield.
- Capture the actual protocol in the note: spin used, final volume, injection map, session date.
- Watch for the drift signature: strong early response, then a plateau blamed on the patient.
A protocol is standardized only when draw volume, anticoagulant, relative centrifugal force and spin time, single versus double spin, leukocyte content, activation, needle gauge, injection depth and spacing, volume per zone, and visit interval are all specified in writing and recorded per treatment.
How is platelet-rich plasma prepared for scalp treatment, and which preparation variables change the final product?
Preparation looks like four routine minutes of lab work, and every one of those minutes is a fork where the final product changes. You're not making a fixed substance, you're making whatever your particular tube, force, and technique hand you. That's why the only honest answer to "how concentrated is your PRP" comes from a platelet count, not from a brochure.
- Draw and anticoagulate: sodium citrate or acid citrate dextrose protect platelet membranes better than EDTA, so the choice of tube is already a variable.
- Spin: force and time together decide how completely red cells sediment and how many platelets you recover into the plasma above them.
- Single or double: one moderate spin gives you more plasma at a lower multiple; a second higher-force spin concentrates it into a smaller volume, though the reported ranges overlap.
- Decide on leukocytes: neutrophils bring proteases and inflammatory mediators, and there's no consensus for the scalp, so this is a documented choice rather than an accident.
- Activate or don't: platelets degranulate on contact with dermal collagen anyway, so many scalp protocols skip calcium chloride and accept slower release instead of faster gelation.
- Verify: a periodic platelet count on both whole blood and concentrate turns an assumed multiple into a measured one.
Anticoagulant choice, relative centrifugal force and time, single versus double spin, buffy coat handling, leukocyte content, and activation each change the final injectate independently, and only a periodic platelet count on both whole blood and concentrate confirms what the process is actually producing.
What injection technique, depth, and pattern are used when treating the scalp with PRP?
Everything upstream of the needle is wasted if the plasma lands in fat. You're aiming at a band of dermis roughly two millimeters down, level with the follicular bulge and dermal papilla, and you're hitting it a few hundred times in a row while your hand gets tired. Consistency across that whole grid is the skill, not the individual stick.
- Depth: 1.5 to 2.5 mm into the dermis, shallow of the loose subcutaneous plane.
- Control: 30 or 31 gauge needle with a fixed hub depth or guard.
- Grid: points about 1 cm apart, 0.05 to 0.1 mL each, 3 to 6 mL total.
- Confirmation: a small wheal at each point, mapped to documented miniaturization zones.
Scalp PRP is injected into the dermis at 1.5 to 2.5 millimeters through a 30 or 31 gauge needle in a grid roughly one centimeter apart, delivering 0.05 to 0.1 milliliters per point for a total of 3 to 6 milliliters per session, with a small wheal at each point confirming the plane is correct.
How many PRP sessions are needed and what does a treatment schedule look like over the first year?
Hair grows on a calendar measured in months, so judging PRP at week six is judging noise. Nearly every protocol front-loads the treatment and then asks you to wait through a stretch where nothing visible happens, which is exactly when people quit. Tell patients the timeline up front and the dropouts mostly stop.
- Weeks 0 to 16, induction: three to four sessions four to six weeks apart, stacking growth factor exposure across consecutive hair cycles.
- Weeks 1 to 6, expect noise: shedding can briefly increase as synchronized telogen hairs release.
- Months 2 to 3, first real signal: shedding drops before anything looks thicker.
- Months 4 to 6, visible change: caliber and density become photographically obvious, or they don't, which is your stopping point.
- Months 6 onward, maintenance: one session every three to six months, with the interval set by how fast that patient regresses.
The standard schedule is three to four induction sessions four to six weeks apart followed by maintenance every three to six months, with reduced shedding appearing around two to three months and density and caliber gains between four and six months, and gains regress toward baseline if all treatment stops.
Which patients are good candidates for PRP hair restoration and who is unlikely to respond?
Growth factors work on follicles that are still alive but shrinking. They can wake up a miniaturized follicle and they can't rebuild one that has fibrosed away, so a scalp that's been slick and shiny for years has nothing left to treat. Which is why the workup matters more than the injection, and why the first visit should be a diagnosis rather than a sale.
PRP works on miniaturized but living follicles, so the best candidates have early to moderate androgenetic alopecia at Norwood II to IV or Ludwig I to II, while a scarred or long-slick scalp has no viable target and a workup covering ferritin, thyroid function, vitamin D, and hormones is required to rule out treatable causes first.
What does the clinical evidence show about how well PRP works for androgenetic alopecia?
The randomized evidence is positive, modest, and messy, and the messiness has a cause rather than a mystery. Pooled trials used different draw volumes, different spins, different platelet multiples, and different ways of counting hair, so a meta-analysis is averaging a family of related but non-identical treatments. That's also why the pooled number is a weak predictor of what any single clinic will get.
- Density gain: commonly 15 to 30 hairs per square centimeter over baseline or control at 3 to 6 months.
- Also measured: increased shaft diameter and a higher proportion of hairs in anagen.
- The caveats reviewers flag: high heterogeneity, small samples, short follow-up, publication bias.
- Durability: few trials run past 6 to 12 months, and gains regress without maintenance.
- Regulatory status: off label in the US; centrifuge systems hold clearance as blood separation devices, no PRP preparation is FDA approved for hair loss.
Placebo-controlled and half-head trials commonly report increases of 15 to 30 hairs per square centimeter over three to six months with measurable gains in shaft diameter and anagen proportion, but systematic reviews flag high heterogeneity, small samples, and short follow-up, and PRP for hair restoration remains an off-label use in the United States.
What are the risks, side effects, and contraindications of scalp PRP injections?
Because you're injecting the patient's own blood, the two risks that dominate other injectables, allergy to the product and disease transmission, mostly fall away. Don't let that framing relax you, because it hides the two that remain. Contamination is a handling failure, not a biology one, and the anticoagulant, activator, and anesthetic in the room aren't autologous at all.
Scalp PRP risk is procedural rather than immunologic, dominated by pinpoint bleeding, tenderness usually resolving within about 24 hours, and transient swelling, with contraindications including active infection, active hematologic malignancy, current chemotherapy, and platelet function disorders, and current consensus guidance placing the thrombocytopenia threshold at a platelet count of 50,000 per cubic millimeter outside hematologic malignancy.
How does PRP compare with minoxidil, finasteride, and hair transplant surgery?
These aren't four items on a shortlist where you pick one. They act at different points of the same disease, so they stack. Only the antiandrogens slow the process that's causing the loss, and only surgery adds follicles that weren't there.
| Criteria | Daily medical therapy | PRP | Transplant surgery |
|---|---|---|---|
| Mechanism | Minoxidil prolongs anagen; finasteride and dutasteride block testosterone to DHT conversion | Episodic bolus of platelet growth factors to dermal papilla and follicular stem cells | Relocates DHT-resistant follicles from occipital donor area |
| Adds follicles | No | No | Yes |
| Schedule | Daily, indefinitely | Repeat clinic visits, no daily compliance | One-time procedure, plus ongoing medical therapy |
| Main burden | Scalp irritation, unwanted facial hair, small but real incidence of sexual side effects | Needles, clinic time, out-of-pocket cost | Cost, downtime, surgical risk |
| Density effect | Reference standard for medical therapy | Broadly comparable to minoxidil, not a category apart | Largest, but limited by donor supply |
Minoxidil and finasteride are daily therapies that prolong anagen and suppress DHT respectively, PRP delivers episodic growth factor stimulation with density gains broadly comparable to minoxidil rather than dramatically above it, and only transplant surgery adds follicles, which is why the usual sequence starts with the antiandrogen and topical and layers PRP on top.
What does PRP for hair loss cost, and what drives the price differences between clinics?
No authority sets any of these numbers. Every practice prices its own, and a threefold spread between two clinics across town can be entirely legitimate or entirely not. The way to tell is to price the full protocol including maintenance rather than the first visit, because a cheap induction package followed by mandatory quarterly sessions isn't cheap.
A single scalp PRP session commonly runs 500 to 1,500 dollars in the United States with a three-session induction course packaged between 1,500 and 4,000 dollars and a realistic first-year total of 2,000 to 5,000 dollars, driven mainly by provider chair time and office overhead rather than the 40 to 150 dollar separation kit, and insurance essentially never covers it because the use is cosmetic and off label.
What training, credentials, and equipment should a provider have before offering PRP for hair loss?
Who's allowed to do what is set by state law, not by the procedure, and a delegation model that's perfectly legal in one state is unlicensed practice across the line. Authorization is only half of it though. The half that gets skipped is diagnosis: a weekend certificate covering injection mechanics leaves you injecting growth factors into conditions that needed something else entirely. And the layer that's missing in almost every new practice is paperwork, meaning off-label consent stating plainly that the treatment isn't FDA approved for hair restoration, a treatment record capturing the actual parameters used, and a defined process for reporting an adverse event.
Scope of practice for the draw, the processing, and the injections is set by state law and must be confirmed locally in writing, while competence also requires diagnostic skill to distinguish androgenetic alopecia from telogen effluvium, alopecia areata, and scarring alopecias, supervised hands-on training on the practice's own device, a validated centrifuge with single-use cleared kits, standardized photography, and off-label informed consent stating the treatment is not FDA approved for hair restoration.
